SNDXNasdaq United States
Market cap
$1.822 B
$20.40 +3.24%
Close of 7 Aug 2026
Revenue
$172.4M
#2349 by revenue
Earnings
-$285.4M
Loss-making
Shares outstanding
89,297,086
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Syndax Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.